Literature DB >> 17720390

Maintenance of myocyte volume homeostasis during stress by diazoxide is cardioprotective.

Ashraf S Al-Dadah1, Rochus K Voeller, Richard B Schuessler, Ralph J Damiano, Jennifer S Lawton.   

Abstract

BACKGROUND: We previously demonstrated that myocyte swelling and reduced contractility secondary to hyperkalemic cardioplegia and hyposmotic stress are attenuated by the addition of diazoxide, an adenosine triphosphate-sensitive potassium channel (K(ATP)) opener. The goal of this study was to investigate the effect of diazoxide on myocyte swelling and reduced contractility after metabolic inhibition and to attempt to summarize the potential mechanisms involved.
METHODS: Isolated rabbit myocytes were perfused with Tyrode's control solution for 20 minutes, followed by test solution for 20 minutes. Test solutions included (1) Tyrode's control, (2) a metabolic inhibition solution containing sodium cyanide and 2-deoxyglucose, (3) metabolic inhibition plus diazoxide, (4) metabolic inhibition plus diazoxide plus HMR1098 (a sarcolemmal K(ATP)-channel blocker), or (5) metabolic inhibition plus diazoxide plus 5-hydroxydeconoate (a mitochondrial K(ATP)-channel blocker). Myocytes were then reexposed to Tyrode's solution for 20 minutes. Volume measurements were taken every 5 minutes. Contractility was recorded using edge-detection software at baseline and at 10 and 20 minutes of reexposure to Tyrode's solution.
RESULTS: Simulated ischemia (metabolic inhibition) caused significant myocyte swelling and associated reduced contractility. The addition of diazoxide abolished myocyte swelling and attenuated the associated reduced contractility. Observations with diazoxide were unchanged by the addition of HMR 1098 or 5-hydroxydeconoate.
CONCLUSIONS: Diazoxide, with or without either K(ATP)-channel blocker, attenuated the significant myocyte swelling and reduced contractility secondary to metabolic inhibition. These data suggest a role for diazoxide, independent of the K(ATP) channel, in myocyte volume homeostasis. In addition, the prevention of myocyte swelling resulted in improved contractility, consistent with previous data and the hypothesis that myocyte swelling may participate in the phenomenon of myocardial stunning.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720390     DOI: 10.1016/j.athoracsur.2007.04.103

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Cardioprotective benefits of adenosine triphosphate-sensitive potassium channel opener diazoxide are lost with administration after the onset of stress in mouse and human myocytes.

Authors:  M Burhan Janjua; Carol M Makepeace; Melissa M Anastacio; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  J Am Coll Surg       Date:  2014-06-03       Impact factor: 6.113

2.  Diazoxide Cardioprotection Is Independent of Adenosine Triphosphate-Sensitive Potassium Channel Kir6.1 Subunit in Response to Stress.

Authors:  Matthew C Henn; M Burhan Janjua; Haixia Zhang; Evelyn M Kanter; Carol M Makepeace; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  J Am Coll Surg       Date:  2015-02-21       Impact factor: 6.113

3.  An open sarcolemmal adenosine triphosphate-sensitive potassium channel is necessary for detrimental myocyte swelling secondary to stress.

Authors:  Angela D Sellitto; Ashraf S Al-Dadah; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  Circulation       Date:  2011-09-13       Impact factor: 29.690

4.  Increased tolerance to stress in cardiac expressed gain-of-function of adenosine triphosphate-sensitive potassium channel subunit Kir6.1.

Authors:  Matthew C Henn; M Burhan Janjua; Haixia Zhang; Evelyn M Kanter; Carol M Makepeace; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  J Surg Res       Date:  2016-08-12       Impact factor: 2.192

5.  Superior diastolic function with KATP channel opener diazoxide in a novel mouse Langendorff model.

Authors:  Carol M Makepeace; Alejandro Suarez-Pierre; Evelyn M Kanter; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  J Surg Res       Date:  2018-03-22       Impact factor: 2.192

Review 6.  Multiplicity of effectors of the cardioprotective agent, diazoxide.

Authors:  William A Coetzee
Journal:  Pharmacol Ther       Date:  2013-06-19       Impact factor: 12.310

7.  Diazoxide maintenance of myocyte volume and contractility during stress: evidence for a non-sarcolemmal K(ATP) channel location.

Authors:  Angela D Sellitto; Sara K Maffit; Ashraf S Al-Dadah; Haixia Zhang; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  J Thorac Cardiovasc Surg       Date:  2010-11       Impact factor: 5.209

8.  Inhibition of Succinate Dehydrogenase by Diazoxide Is Independent of the ATP-Sensitive Potassium Channel Subunit Sulfonylurea Type 1 Receptor.

Authors:  Melissa M Anastacio; Evelyn M Kanter; Angela D Keith; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  J Am Coll Surg       Date:  2013-03-25       Impact factor: 6.113

9.  Relationship between mitochondrial matrix volume and cellular volume in response to stress and the role of ATP-sensitive potassium channel.

Authors:  Melissa M Anastacio; Evelyn M Kanter; Carol M Makepeace; Angela D Keith; Haixia Zhang; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

10.  Cardioprotective mechanism of diazoxide involves the inhibition of succinate dehydrogenase.

Authors:  Melissa M Anastacio; Evelyn M Kanter; Carol Makepeace; Angela D Keith; Haixia Zhang; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  Ann Thorac Surg       Date:  2013-05-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.